Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL27734811 | 0.97 | TSHR (0.35) | TSHRTDP1ALDH1A1 | |
| SCHEMBL17524669 | 0.87 | TSHR (0.33) | TSHRTDP1ALDH1A1 | |
| SCHEMBL5879279 | 0.79 | TSHR (0.43) | TSHRTDP1ALDH1A1 | |
| SCHEMBL14611297 | 0.76 | — | — | |
| SCHEMBL6479247 | 0.76 | — | — | |
| SCHEMBL7982360 | 0.76 | — | — | |
| SCHEMBL28606113 | 0.73 | — | — | |
| SCHEMBL11708331 | 0.73 | ALDH1A1 (0.37) | ALDH1A1 | |
| SCHEMBL1938740 | 0.73 | — | — | |
| SCHEMBL27921123 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103260617-B | Comprise the pharmaceutical preparation of NSAID and cyclodextrin | 雷克特本克斯尔医疗保健国际有限公司 | 2016-08-24 | — | — | CN | claimed |
| CN-102282301-B | Electrospinning of ptfe with high viscosity materials | ZEUS IND PRODUCTS INC | 2014-07-30 | — | — | CN | claimed |
| CN-103260617-A | Novel pharmaceutical formulation comprising NSAID and cyclodextrin | RECKITT BENCKISER HEALTHCARE INT LTD | 2013-08-21 | — | — | CN | claimed |
| CN-102282301-A | ELECTROSPINNING OF PTFE WITH HIGH VISCOSITY MATERIALS | — | 2011-12-14 | — | — | CN | claimed |
| EP-1784176-B1 | COMPOSITION COMPRISING LACTIC ACID AND LACTOFERRIN | NESTOR MEDICAL AB (SE) | 2010-04-14 | — | — | EP | claimed |
| CN-1317977-A | Dry powder active agent pulmonary delivery | INHALE THERAPEUTIC SYST (US) | 2001-10-17 | — | — | CN | claimed |
| CN-1144813-A | Hypoallergenic coating composition for latex rubber gloves | WITCO CORP (US) | 1997-03-12 | — | — | CN | claimed |
| CN-107427003-B | Combination therapy | 梅制药公司 | 2023-01-31 | — | — | CN | disclosed |
| CN-109553329-A | A kind of composite stone matter flexible sheet material and preparation method thereof | 亚士创能新材料(滁州)有限公司 | 2019-04-02 | — | — | CN | disclosed |
| CN-109397479-A | A kind of preparation method of flexible imitative flag material | 亚士创能新材料(滁州)有限公司 | 2019-03-01 | — | — | CN | disclosed |
| US-20180030207-A1 | LINEAR CYCLODEXTRIN COPOLYMERS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2018-02-01 | — | — | US | disclosed |
| CN-107427003-A | Combination therapy | 梅制药公司 | 2017-12-01 | — | — | CN | disclosed |
| CN-104958296-B | Antimicrobial compositions | 麦林塔医疗有限公司 | 2017-12-01 | — | — | CN | disclosed |
| WO-2000033885-A1 | SUPRAMOLECULAR COMPLEXES CONTAINING THERAPEUTIC AGENTS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2000-06-15 | — | — | WO | disclosed |
| CN-1244251-A | Barrier member and products made therefrom | ALLIEDSIGANAL INC (US) | 2000-02-09 | — | — | CN | disclosed |
| CN-1238040-A | Blast resistant and blast-oriented container assembly | ALLIED SIGNAL INC (US) | 1999-12-08 | — | — | CN | disclosed |
| CN-1144813-A | Hypoallergenic coating composition for latex rubber gloves | WITCO CORP (US) | 1997-03-12 | — | — | CN | disclosed |
| EP-0409781-B1 | Polymer base blend compositions containing destructurized starch | WARNER LAMBERT CO (US) | 1994-06-01 | — | — | EP | disclosed |
| US-5095054-A | Molding premixes of a melt of a degraded starch and hydrophobic water-insoluble thermoplastic polymer; dimensional stability; toughness; humidity resistance; receptivity | WARNER-LAMBERT COMPANY (US) | 1992-03-10 | — | — | US | disclosed |
| EP-0409781-A2 | Polymer base blend compositions containing destructurized starch | WARNER-LAMBERT COMPANY (US) | 1991-01-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180030207-A1 | LINEAR CYCLODEXTRIN COPOLYMERS | DDOST, SI, PDIA6 | TSHR 4451/4885TDP1 2773/4885ALDH1A1 2852/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.